Screener
Emergent Biosolutions EBS Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other liabilities | 35.4 | 53.9 |
| Total liabilities | 775.4 | 796.0 |
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value per share; 15.0 shares authorized, no shares issued or outstanding | — | — |
| Common stock, $0.001 par value per share; 200.0 shares authorized, 61.9 and 60.9 shares issued; 51.3 and 52.1 shares outstanding, respectively | 0.1 | 0.1 |
| Treasury stock, at cost, 10.7 and 8.7 common shares, respectively | (270.5) | (252.6) |
| Additional paid-in capital | 951.8 | 942.4 |
| Accumulated other comprehensive loss, net | (6.8) | (7.5) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's preferred stock, shares authorized?
- Emergent Biosolutions (EBS) reported preferred stock, shares authorized of $15M in Q2 2026.
- How has Emergent Biosolutions's preferred stock, shares authorized changed year-over-year?
- Emergent Biosolutions's preferred stock, shares authorized decreased by 0.0% year-over-year, from $15M to $15M.
- What is the long-term trend for Emergent Biosolutions's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Emergent Biosolutions's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $15M to $15M.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about Emergent Biosolutions's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude